EGFR and glioblastoma: The glioblastoma growth and proliferation are inhibited when PDK1 and epidermal growth factor receptor (EGFR) are targeted together, reversing the Warburg effect through decreased HIF-1 expression, shifting the Warburg phenotype to OXPHOS, and inhibiting glioblastoma multiforme growth and proliferation [180].